David Happel - 26 Mar 2024 Form 4 Insider Report for Sagimet Biosciences Inc. (SGMT)

Signature
/s/ Elizabeth Rozek, Attorney-in-Fact
Issuer symbol
SGMT
Transactions as of
26 Mar 2024
Net transactions value
+$63,731
Form type
4
Filing time
28 Mar 2024, 16:08:37 UTC
Previous filing
08 Dec 2023
Next filing
07 Feb 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGMT Series A Common Stock Purchase $63,731 +12,100 +1.9% $5.27 639,200 26 Mar 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the weighted average price. The shares were purchased in multiple transactions at prices ranging from $5.24 per share to $5.2999 per share. The Reporting Person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each price.